Publication:
VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression.

dc.contributor.authorDelgado-Bellido, Daniel
dc.contributor.authorFernández-Cortés, Mónica
dc.contributor.authorRodríguez, María Isabel
dc.contributor.authorSerrano-Sáenz, Santiago
dc.contributor.authorCarracedo, Arkaitz
dc.contributor.authorGarcia-Diaz, Angel
dc.contributor.authorOliver, F Javier
dc.date.accessioned2023-01-25T10:09:28Z
dc.date.available2023-01-25T10:09:28Z
dc.date.issued2018-05-21
dc.description.abstractAberrant extra-vascular expression of VE-cadherin (VEC) has been observed in metastasis associated with vasculogenic mimicry (VM); however, the ultimate reason why non-endothelial VEC favors the acquisition of this phenotype is not established. In this study, we show that human malignant melanoma cells have a constitutively high expression of phoshoVEC (pVEC) at Y658; pVEC is a target of focal adhesion kinase (FAK) and forms a complex with p120-catenin and the transcriptional repressor kaiso in the nucleus. FAK inhibition enabled kaiso to suppress the expression of its target genes and enhanced kaiso recruitment to KBS-containing promoters. Finally we have found that ablation of kaiso-repressed genes WNT11 and CCDN1 abolished VM. Thus, identification of pVEC as a component of the kaiso transcriptional complex establishes a molecular paradigm that links FAK-dependent phosphorylation of VEC as a major mechanism by which ectopical VEC expression exerts its function in VM.
dc.identifier.doi10.1038/s41418-018-0125-4
dc.identifier.essn1476-5403
dc.identifier.pmcPMC6329820
dc.identifier.pmid29786069
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329820/pdf
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41418-018-0125-4.pdf
dc.identifier.urihttp://hdl.handle.net/10668/12494
dc.issue.number2
dc.journal.titleCell death and differentiation
dc.journal.titleabbreviationCell Death Differ
dc.language.isoen
dc.organizationCentro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO
dc.page.number348-361
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshAntigens, CD
dc.subject.meshCadherins
dc.subject.meshCatenins
dc.subject.meshCell Line, Tumor
dc.subject.meshCyclin D1
dc.subject.meshFocal Adhesion Kinase 1
dc.subject.meshGene Expression
dc.subject.meshGene Knockout Techniques
dc.subject.meshHEK293 Cells
dc.subject.meshHuman Umbilical Vein Endothelial Cells
dc.subject.meshHumans
dc.subject.meshMelanoma
dc.subject.meshNeovascularization, Pathologic
dc.subject.meshPhosphorylation
dc.subject.meshSkin Neoplasms
dc.subject.meshTranscription Factors
dc.subject.meshTransduction, Genetic
dc.subject.meshWnt Proteins
dc.subject.meshDelta Catenin
dc.titleVE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number26
dspace.entity.typePublication

Files